Clinical experience with single-nucleotide polymorphism-based non-invasive prenatal screening for 22q11.2 deletion syndrome

Ultrasound in Obstetrics and Gynecology

Volumn 47, Issue 2, 2016, Pages 177-183

  Gross, S J ^a   Stosic, M ^a   McDonald Mcginn, D M ^b   Bassett, A S ^c   Norvez, A ^a   Dhamankar, R ^a   Kobara, K ^a   Kirkizlar, E ^a   Zimmermann, B ^a   Wayham, N ^a   Babiarz, J E ^a   Ryan, A ^a   Jinnett, K N ^a   Demko, Z ^a   Benn, P ^d  

^a NATERA INC   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

22q11.2 deletion syndrome; cardiac defects; microdeletions; NIPT; ultrasound

Indexed keywords

ADULT; DIGEORGE SYNDROME; EMBRYOLOGY; EVALUATION STUDY; FALSE POSITIVE RESULT; FEMALE; GENETIC SCREENING; GENETICS; GESTATIONAL AGE; HIGH RISK PREGNANCY; HUMAN; PREDICTIVE VALUE; PREGNANCY; PRENATAL DIAGNOSIS; PROCEDURES; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; DIGEORGE SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; GENETIC TESTING; GESTATIONAL AGE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY, HIGH-RISK; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES;

EID: 84957441683     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.15754     Document Type: Article

References (29)

1. Larion S, Warsof SL, Romary L, Mlynarczyk M, Peleg D, Abuhamad AZ,. Uptake of noninvasive prenatal testing at a large academic referral center. Am J Obstet Gynecol 2014; 211: 651.e1-651.e7.
2. Dar P, Curnow KJ, Gross SJ, Hall MP, Stosic M, Demko Z, Zimmermann B, Hill M, Sigurjonsson S, Ryan A, Banjevic M, Kolacki PL, Koch SW, Strom CM, Rabinowitz M, Benn P,. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing. Am J Obstet Gynecol 2014; 211: 527.e1-527.e17.
3. American Congress of Obstetricians and Gynecologists. Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol 2012; 120: 1532-1534.
4. Wapner RJ, Babiarz JE, Levy B, Stosic M, Zimmermann B, Sigurjonsson S, Wayham N, Ryan A, Banjevic M, Lacroute P, Hu J, Hall MP, Demko Z, Siddiqui A, Rabinowitz M, Gross SJ, Hill M, Benn P,. Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes. Am J Obstet Gynecol 2014; 212: 332.e1-332.e9.
5. th edn). Saunders Elsevier: Philadelphia, PA, 2007.
6. Sullivan KE,. Chromosome 22q11.2 deletion syndrome: DiGeorge syndrome/velocardiofacial Syndrome. Immunol Allergy Clin North Am 2008; 28: 353-366.
7. Botto LD, May K, Fernhoff PM, Correa A, Coleman K, Rasmussen SA, Merritt RK, O'Leary LA, Wong LY, Elixson EM, Mahle WT, Campbell RM,. A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 2003; 112: 101-107.
8. Wapner RJ, Martin CL, Levy B, Ballif BC, Eng CM, Zachary JM, Savage M, Platt LD, Saltzman D, Grobman DA, Klugman S, Scholl T, Simpson JL, McCall K, Aggarwal VS, Bunke B, Nahum O, Patel A, Lamb AN, Thom EA, Beaudet AL, Ledbetter DH, Shaffer LG, Jackson L,. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med 2012; 367: 2175-2184.
9. Grati FR, Molina Gomes D, Ferreira JC, Dupont C, Alesi V, Gouas L, Horelli-Kuitunen N, Choy KW, Martinez-Conejero JA, Gonzales de la Vega A, Piotrowski K, Genesio R, Queipo GF, Malvestiti B, Herve B, Benzacken B, Novelli A, Vago P, Piippo K, Leung TY, Malvestiti F, Quibel T, Tabet AC, Simoni G, Vialard F,. Prevalence of recurrent pathogenic microdeletions and microduplications in over 9,500 pregnancies. Prenat Diagn 2015; 35: 801-809.
10. Bassett AS, McDonald-McGinn DM, Devriendt K, Digilio MC, Goldenberg P, Habel A, Marino B, Oskarsdottir S, Philip N, Sullivan K, Swillen A, Vorstman J; International 22q11.2 Deletion Syndrome Consortium. Practical guidelines for managing patients with 22q11.2 deletion syndrome. J Pediatr 2011; 159: 332-339.
11. Cheung EN, George SR, Andrade DM, Chow EW, Silversides CK, Bassett AS,. Neonatal hypocalcemia, neonatal seizures, and intellectual disability in 22q11.2 deletion syndrome. Genet Med 2014; 16: 40-44.
12. Vora NL, O'Brien BM,. Noninvasive prenatal testing for microdeletion syndromes and expanded trisomies: proceed with caution. Obstet Gynecol 2014; 123: 1097-1099.
13. Samango-Sprouse C, Banjevic M, Ryan A, Sigurjonsson S, Zimmermann B, Hill M, Hall MP, Westemeyer M, Saucier J, Demko A, Rabinowitz M,. SNP-based non-invasive prenatal testing detects sex chromosome aneuploidies with high accuracy. Prenat Diagn 2013; 33: 643-649.
14. Nicolaides KH, Syngelaki A, Gil M, Atanasova V, Markova D,. Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y. Prenat Diagn 2013; 33: 575-579.
15. Nicolaides KH, Syngelaki A, Gil MD, Quezada MS, Zinevich Y,. Prenatal detection of fetal triploidy from cell-free DNA testing in maternal blood. Fetal Diagn Ther 2014; 35: 212-217.
16. Pergament E, Cuckle H, Zimmermann B, Banjevic M, Sigurjonsson S, Ryan A, Hall MP, Dodd M, Lacroute P, Stosic M, Chopra N, Hunkapiller N, Prosen DE, McAdoo S, Demko D, Siddiqui A, Hill M, Rabinowitz M,. Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort. Obstet Gynecol 2014; 124: 210-218.
17. Human genome build hg19. http://hgdownload.cse.ucsc.edu/goldenPath/hg19/bigZips/ [Accessed 9 July 2015].
18. Zimmermann B, Hill M, Gemelos G, Demko Z, M Banjevic, Baner J, Ryan A, Sigurjonsson S, Chopra N, Dodd M, Levy B, Rabinowitz M,. Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci. Prenat Diagn 2012; 32: 1233-1241.
19. Shaikh TH, Kurahashi H, Saitta SC, O'Hare AM, Hu P, Roe BA, Driscoll DA, McDonald-McGinn DM, Zackai EH, Budarf ML, Emanuel BS,. Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis. Hum Mol Genet 2000; 9: 489-501.
20. Noel AC, Pelluard F, Delezoide AL, Devisme L, Loeuillet L, Leroy B, Martin A, Bouvier R, Laquerriere A, Jeanne-Pasquier C, Bessieres-Grattagliano B, Mechler C, Alanio E, Leroy C, Gaillard D,. Fetal phenotype associated with the 22q11 deletion. Am J Med Genet A 2014; 164A: 2724-2731.
21. McDonald-McGinn DM, Sullivan KE,. Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine 2011; 90: 1-18.
22. Grande M, Jansen FA, Blumenfeld YJ, Fisher A, Odibo AO, Haak MC, Borrell A,. Genomic microarray in fetuses with increased nuchal translucency and normal karyotype-a systematic review and meta-analysis. Ultrasound Obstet Gynecol 2015; 46: 650-658.
23. Donnelly JC, Platt LD, Rebarber A, Zachary J, Grobman WA, Wapner RJ,. Association of copy number variants with specific ultrasonographically detected fetal anomalies. Obstet Gynecol 2014; 124: 83-90.
24. Hume JH, Wardrop J, Boomer T, Almasri E, Paxton WB, Saldivar JS, Dharajiya N, Monroe YJ, Farkas DH, Grosu DS, McCullough RM,. Clinical outcome of subchromosomal events detected by whole-genome noninvasive prenatal testing. Prenat Diagn 2015; 35: 999-1004.
25. Helgeson J, Wardrop J, Boomer T, Almasri E, Paxton WB, Saldivar JS, Dharajiya N, Monroe TJ, Farkas DH, Grosu DS, McCullough RM,. Clinical outcome of subchromosomal events detected by whole-genome noninvasive prenatal testing. Prenat Diagn 2015; 35: 1-6.
26. Besseau-Ayasse J, Violle-Poirsier C, Bazin A, Gruchy N, Moncla A, Girard F, Till M, Mugneret F, Coussement A, Pelluard F, Jimenez M, Vago P, Portnoï MF, Dupont C, Beneteau C, Amblard F, Valduga M, Bresson JL, Carré-Pigeon F, Le Meur N, Tapia S, Yardin C, Receveur A, Lespinasse J, Pipiras E, Beaujard MP, Teboul P, Brisset S, Catty M, Nowak E, Douet Guilbert N, Lallaoui H, Bouquillon S, Gatinois V, Joly-Helas G, Prieur F, Cartault F, Martin D, Kleinfinger P, Molina Gomes D, Doco-Fenzy M, Vialard F,. A French collaborative survey of 272 fetuses with 22q11.2 deletion: ultrasound findings, fetal autopsies and pregnancy outcomes. Prenat Diagn 2014; 34: 424-430.
27. McDonald-McGinn DM, Emanuel BS, Zackai EH,. 22q11.2 Deletion Syndrome. In GeneReviews, Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Fong CT, Mefford HC, Smith RJH, Stephens K, (eds). University of Washington, Seattle, Seattle, WA, 2013. http://www.ncbi.nlm.nih.gov/books/NBK1523 [Accessed 9 July 2015].
28. Borrell A, Stergiotou I,. Cell-free DNA testing: inadequate implementation of an outstanding technique. Ultrasound Obstet Gynecol 2015; 45: 508-511.
29. Gross SJ, Ryan A, Benn P,. Noninvasive prenatal testing for 22q11.2 deletion syndrome: deeper sequencing increases the positive predictive value. Am J Obstet Gynecol 2015; 213: 254-245.